No Data
No Data
Barclays Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $260
Barclays Reaffirms Their Buy Rating on Veeva Systems (VEEV)
El 70% De Las Empresas De Tecnología Médica Utiliza Procesos Manuales Para Gestionar Contenidos
Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims
Veeva Announces AI in Vault CRM
Salesforce, Workday Are Top Picks at Scotiabank Amid Initiation of 13 Software-service Stocks
No Data
No Data